glp-1 weight loss drugs tirzepatide semaglutide Drug Shake Up: What Patients and Providers Need to Know GLP-1 anti-obesity drugs lead to

Research shows PQQ helps certain enzymes work, especially when it comes to mitochondria

Macular Degeneration In June 2025, a large study of older adults with Type 2 diabetes found those who took a GLP-1 drug had a "substantially higher risk" of developing a rare type of age-related macular degeneration an eye disease that causes blindness than people with diabetes who didn't take the medication

For individuals striving for weight loss without injections, oral Wegovy is a compelling choice

CJC 1295 stimulates growth hormone secretion and will keep a steady increase of HGH and IGF-1 with no increase in prolactin, leading to fat loss, and increased protein synthesis, in turn promoting growth